ASCVD
Clinical trials for ASCVD explained in plain language.
Never miss a new study
Get alerted when new ASCVD trials appear
Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Computer alerts aim to lower heart Patients' cholesterol
Disease control OngoingThis study tests whether electronic alerts in medical records help doctors prescribe stronger cholesterol-lowering medications for heart disease patients with high LDL. About 400 adults with heart disease and LDL over 80 mg/dL, already on a statin, will be randomly assigned to ha…
Matched conditions: ASCVD
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 11:03 UTC
-
New study aims to boost cholesterol treatment in heart disease patients
Disease control ENROLLING_BY_INVITATIONThis study tests different approaches to help patients with high cholesterol and heart disease get the right medicines to lower their cholesterol. About 300 adults at high risk or with established artery disease will take part. The goal is to see which method helps more patients …
Matched conditions: ASCVD
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 10:53 UTC
-
Can a gentler heart drug combo prevent diabetes in At-Risk patients?
Disease control ENROLLING_BY_INVITATIONThis study looks at 4,000 adults with prediabetes and heart disease to see if a low-intensity statin combined with ezetimibe is better than a high-intensity statin alone at preventing new diabetes. Participants will be followed for several years to track diabetes development and …
Matched conditions: ASCVD
Phase: PHASE4 • Sponsor: Seung-Whan Lee, M.D., Ph.D. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Massive study to reveal best diabetes drug for heart health
Knowledge-focused OngoingThis study looks at medical records from 60,000 people with type 2 diabetes and obesity to compare three drugs (dulaglutide, semaglutide, and tirzepatide) against an older drug (sitagliptin). The goal is to see which one is best at preventing heart attacks, strokes, and death. Th…
Matched conditions: ASCVD
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC